Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Finja, Hennig"'
Autor:
Amelie Stalke, Annika Behrendt, Finja Hennig, Holger Gohlke, Nicole Buhl, Thea Reinkens, Ulrich Baumann, Brigitte Schlegelberger, Thomas Illig, Eva‐Doreen Pfister, Britta Skawran
Publikováno v:
Clinical Genetics.
Autor:
Cansu Dumlupinar, Christian Wülfing, Klaus-Peter Dieckmann, Gazanfer Belge, Renate Pichler, Jörg Sommer, Alexander Winter, Pia Paffenholz, Arlo Radtke, Cord Matthies, Finja Hennig, Friedemann Zengerling
Publikováno v:
World Journal of Urology. 40:317-326
Purpose Lymphovascular invasion (LV1) and presence of > 50% embryonal carcinoma (> 50% EC) represent risk factors for progression in patients with clinical stage 1 (CS1) nonseminomatous (NS) testicular germ cell tumours. As serum levels of microRNA-3
Autor:
Klaus-Peter, Dieckmann, Cansu, Dumlupinar, Arlo, Radtke, Cord, Matthies, Renate, Pichler, Pia, Paffenholz, Jörg, Sommer, Alexander, Winter, Friedemann, Zengerling, Finja, Hennig, Christian, Wülfing, Gazanfer, Belge
Publikováno v:
World journal of urology. 40(2)
Lymphovascular invasion (LV1) and presence of 50% embryonal carcinoma ( 50% EC) represent risk factors for progression in patients with clinical stage 1 (CS1) nonseminomatous (NS) testicular germ cell tumours. As serum levels of microRNA-371a-3p (M37
Autor:
Cansu Dumlupinar, Klaus Junker, Francesca Grobelny, Klaus-Peter Dieckmann, Arlo Radtke, Finja Hennig, Gazanfer Belge
Publikováno v:
Oncotarget
Background: Serum levels of microRNA-371a-3p represent a specific tumor marker of testicular germ cell tumors (GCTs) but the origin of circulating miR-371a-3p is not finally resolved. The correlation between miR-levels in tissue and serum is unclear.
Autor:
Raphael Ikogho, Johannes Hammel, Gazanfer Belge, Petra Anheuser, Christian Wülfing, Arlo Radtke, Finja Hennig, Klaus-Peter Dieckmann
Publikováno v:
Urologia internationalis. 100(4)
Background: Accumulating evidence suggests serum levels of microRNA (miR)-371a-3p to be a novel tumour marker of testicular germ cell tumours (GCTs). Presently, there is only limited information regarding the velocity of decline of serum levels in re